Wellbutrin vs Benzodiazepines for Anxiety: A Psychiatric Provider's Clinical Comparison

Medication Review

Not sure if the medication story actually fits?

Best fit when the question is dose, timing, side effects, interactions, diagnosis fit, or what has already failed.

Request a Medication Review Medication management

No. Wellbutrin is bupropion, an antidepressant. It isn't a benzodiazepine such as Xanax, Ativan, Klonopin or Valium.

That distinction matters if you're trying to understand a prescription or considering a change. These medicines have different uses and risks. Neither a calming effect nor an energizing effect tells me what diagnosis you have.

Do not abruptly stop a benzodiazepine or reduce it on your own. Withdrawal can cause seizures and other life-threatening complications, even after prescribed use. Bupropion is not a treatment for benzodiazepine withdrawal. Its label specifically contraindicates use during abrupt benzodiazepine or alcohol discontinuation.

If you have a seizure, trouble breathing, suspected overdose or immediate danger of harming yourself, call 911. For suicidal thoughts or a mental health crisis, call or text 988; immediate danger requires emergency care.

The FDA Wellbutrin XL label and FDA benzodiazepine warning explain those differences and precautions.

The fast answer

Wellbutrin XL treats major depressive disorder and prevents seasonal depressive episodes in people with seasonal affective disorder. It is not FDA-approved for anxiety disorders.
Bupropion can help anxiety symptoms in some people with depression. That evidence does not establish it as a replacement for a benzodiazepine.
Benzodiazepines have legitimate clinical uses, including some anxiety indications. Sedation, interactions, physical dependence and withdrawal need ongoing review.
Physical dependence is different from addiction. Taking a medicine as prescribed can still lead to dependence.
Medication changes need an individualized prescriber plan. A low dose or an "as needed" label doesn't establish that stopping is safe.

I want the diagnosis, medication history and safety risks on the same page before choosing a treatment.

Not every article needs an appointment. Use this page for research. Turn it into a visit when the pattern is affecting a real medication, diagnosis, or daily-function decision.

Turn this into a visit when

You are changing, stopping, restarting, or adding a psychiatric medication.
Side effects are shaping the decision more than the original symptom is.
The medication partly helps, but the diagnosis, sleep, labs, or timing still do not fit.

Bring this pattern

current medication listdose and timingside effectssleep patternprior trials

Available for appropriate patients in California and Arizona.

What the comparison actually shows

Question	Wellbutrin / bupropion	Benzodiazepines
What kind of medicine?	An antidepressant; not a controlled substance	A class of controlled medicines, including alprazolam, lorazepam, clonazepam and diazepam
How does it work?	Thought to act through norepinephrine and dopamine pathways; its antidepressant mechanism isn't fully understood	Act at GABA receptors, producing calming or sedating effects
How quickly?	Depression benefit may take several weeks; it isn't a rescue medicine for a panic attack	Often act more quickly, but onset and duration vary by medicine and formulation
What does the anxiety evidence mean?	Stronger evidence concerns anxiety symptoms within depression; primary anxiety evidence is limited	Some products have anxiety indications; ongoing use requires reassessing benefits and risks
Main safety questions?	Seizure risk, activation, blood pressure, bipolar history and interactions	Sedation, breathing risk with other depressants, dependence and withdrawal
Can I switch myself?	No	No; abrupt stopping can be dangerous

The medication and safety rows use the FDA label and class warning linked above. The anxiety evidence row draws on the Papakostas and Bystritsky studies discussed below. I don't use this table as a prescribing algorithm. Feeling tired, wired or overwhelmed is a reason to investigate further.

What Wellbutrin XL is approved for

Wellbutrin XL is approved for major depressive disorder and prevention of seasonal major depressive episodes in people with seasonal affective disorder. It is not FDA-approved for generalized anxiety disorder, panic disorder or ADHD.

The brand and formulation matter. Zyban is a bupropion product approved as an aid to smoking cessation. That doesn't make smoking cessation an approved indication for Wellbutrin XL. Immediate-release, sustained-release and extended-release products also have different prescribing instructions.

Bupropion doesn't inhibit serotonin reuptake the way an SSRI does. Its action is thought to involve norepinephrine and dopamine, although the FDA label says its antidepressant mechanism is unknown. A neurotransmitter description cannot tell me whether it will help your anxiety.

I check the actual bottle and treatment goal. "I'm taking Wellbutrin" leaves out information that can affect safety. See the FDA label, sections 1, 12.1 and 17.

Before you keep searching

If this answer changes what you might do next, pick the next clinical question now.

Care path Turn this into a medication review Bring your current list. Dose, timing, side effects, interactions, and the labs nobody ordered — reviewed in one visit. Side effects or safety question Sort expected activation from dose, timing, blood pressure, sleep, or stop-and-call symptoms. Dose or formulation question Compare 150mg, 300mg, XL, SR, timing, seizure risk, and what to check before increasing.

Or read how medication management works

What the anxiety evidence does and doesn't say

Depression can include substantial anxiety. A person can also have depression and a separate anxiety disorder. I need to distinguish those patterns rather than treating every report of anxiety as the same condition.

Papakostas and colleagues pooled ten randomized depression trials. Anxiety symptoms improved to a similar degree with bupropion and SSRIs across that overall major-depression population (Papakostas et al., 2008; PMID: 17631898).

A separate pooled analysis focused on depression with high anxiety and found a modest response advantage for SSRIs. So I wouldn't tell a highly anxious patient that bupropion and an SSRI are interchangeable in every situation (Papakostas et al., 2008; PMID: 18605812).

Neither analysis was a bupropion-versus-benzodiazepine trial. Neither establishes that bupropion treats primary anxiety disorders as well as it treats depression.

There is a small randomized pilot comparing bupropion XL with escitalopram in generalized anxiety disorder. It enrolled 24 people and reported preliminary benefit, with the authors calling for more research. I don't turn a pilot that size into a routine first-choice recommendation (Bystritsky et al., 2008; PMID: 18362870).

For generalized anxiety and panic disorder, cognitive behavioral therapy and selected antidepressants have a better-established place in treatment guidelines. The choice depends on the diagnosis, severity, prior response and patient preference. NICE recommends limiting benzodiazepines in GAD to short-term crisis use and advises against them for panic disorder; those are treatment recommendations, not a claim that every existing prescription should be stopped. See NICE CG113.

Side effects that need a real plan

Bupropion can cause anxiety, agitation, insomnia, nausea, dry mouth and palpitations. It can also raise blood pressure. The FDA label calls for blood-pressure monitoring and assessment for bipolar disorder.

I don't promise that feeling wired will disappear by a particular week. New or worsening agitation, panic or sleep disruption deserves a conversation with the prescriber. Reduced need for sleep with unusually elevated or irritable mood, reckless behavior or racing thoughts needs prompt assessment for mania.

The antidepressant boxed warning concerns increased suicidal thoughts and behavior in children, adolescents and young adults. Monitoring matters at every age, especially after starting treatment or changing a dose. Suicidal thoughts, psychosis or an inability to stay safe should never be treated as an adjustment phase to wait out. See the FDA label, sections 5 and 6.

Sexual side effects are also a valid reason for review. In two depression trials, bupropion XL caused less treatment-emergent sexual dysfunction than escitalopram. That does not mean sexual side effects are impossible, or that switching will preserve anxiety control for every person (Clayton et al., 2006; PMID: 16841623).

I want to know what changed, when it changed and how much it interferes with your life. Don't add bupropion to an SSRI or replace an effective anxiety treatment on your own.

Seizure risk changes the decision

Bupropion's seizure risk is dose-related. Wellbutrin XL is contraindicated in people with a seizure disorder, current or prior bulimia or anorexia nervosa, and those undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates or antiepileptic drugs.

The prescriber also needs the full medication list, including other bupropion products and medicines that can lower the seizure threshold. Liver or kidney problems can affect prescribing. These are reasons for individualized review, not a home dose-selection checklist. See the FDA label, sections 4, 5.3, 7 and 8.

If a seizure occurs while taking Wellbutrin XL, seek emergency care. The FDA label directs patients to stop Wellbutrin XL and not take it again after a seizure; contact the prescriber urgently.

I take that warning literally. Bupropion cannot make an abrupt benzodiazepine stop safe.

What benzodiazepines can help with

Xanax is alprazolam, Ativan is lorazepam, Klonopin is clonazepam and Valium is diazepam. They belong to the same class but aren't interchangeable. Their approved uses, onset and duration differ.

Benzodiazepines can relieve anxiety in appropriate clinical situations. Some products are also used for seizures, insomnia or medical procedures. That relief is a real effect. I assess it alongside sedation, dizziness, impaired functioning and interactions rather than calling it "just masking symptoms." See the FDA class warning.

Alcohol, opioids and other medicines that depress the nervous system can increase breathing and overdose risks when combined with benzodiazepines. Don't drink alcohol with them. Tell every prescriber about all sedating medicines and substances you use.

A short prescription still needs a purpose and review plan. I don't use a universal maximum number of doses per week as a guarantee against dependence.

Dependence is not the same as addiction

Physical dependence means the body has adapted to repeated exposure, so a dose reduction or stopping can produce withdrawal. Addiction, or a substance use disorder, involves a broader pattern of impaired control and continued use despite harm. Dependence alone doesn't establish that diagnosis.

The FDA warns that physical dependence can develop after days to weeks of steady use, even when a benzodiazepine is taken as prescribed. The 2025 joint tapering guideline also stresses that clinicians shouldn't presume a substance use disorder merely because someone is dependent (Brunner et al., 2025; PMID: 40526204).

I don't treat withdrawal symptoms as a character flaw. I do need to know about missed-dose anxiety, tremor, insomnia, confusion, increased use or difficulty following the prescription.

Those details help separate withdrawal, return of the original condition and medication adverse effects. They can overlap; a symptom diary doesn't establish the diagnosis by itself.

A taper is a plan, not a calendar

Don't cut, skip or stop benzodiazepine doses based on an article. The FDA and joint guideline call for an individualized, monitored approach when tapering is appropriate.

The prescriber weighs the benefits of continued treatment against its risks, then considers the medicine, dose, duration, prior withdrawal, other substances and medical history. The pace may need adjustment as symptoms change. Some long-term tapers take months or years; no article can promise a finish date.

Severe or complicated withdrawal can require inpatient or other medically managed care. A prior withdrawal seizure is especially relevant. The guideline supports treating coexisting conditions and offering psychological support, including CBT when appropriate (Brunner et al., 2025; PMID: 40526204; DOI: 10.1007/s11606-025-09499-2).

I want a plan for who to contact if symptoms worsen, not just instructions for the next reduction. If you're running out of a regularly taken benzodiazepine, contact the prescriber promptly rather than waiting for withdrawal to decide the next step.

Can Wellbutrin and a benzodiazepine be taken together?

This needs a prescriber review of your situation. Having both medicines on a list doesn't tell me why they were prescribed, whether the combination still fits or whether withdrawal risk is present.

I don't automatically add a benzodiazepine to cover bupropion startup symptoms. Worsening anxiety or insomnia needs assessment, and regular benzodiazepine use can create dependence even during a seemingly short "bridge."

Bupropion is not a benzodiazepine substitute or withdrawal treatment. A carefully supervised taper is different from abrupt discontinuation, but a clinician must assess seizure risk and the underlying condition before deciding whether bupropion belongs in the plan. See the FDA contraindications and joint tapering guideline.

Don't start, combine or change either medicine without the prescriber who knows your history.

ADHD needs its own assessment

Task overload, procrastination and poor concentration can be part of ADHD. They can also occur with anxiety, depression, sleep problems or other conditions. Feeling calmer after caffeine, or checking several boxes online, cannot establish ADHD.

I look for a persistent developmental pattern, impairment across settings and other explanations. NICE requires a full clinical and developmental assessment rather than a diagnosis based on a rating scale alone. See NICE NG87 and NIMH's ADHD overview.

Bupropion is sometimes used off-label for adult ADHD. A Cochrane review found possible benefit but rated the evidence low quality, with uncertainty about long-term outcomes. That is not evidence that bupropion will resolve anxiety attributed to ADHD (Verbeeck et al., 2017; PMID: 28965364).

I assess both conditions when both are plausible. One label shouldn't erase the other.

What needs investigating before a change

I start with the symptom timeline, sleep, functioning, substance use and the actual medication pattern. Anxiety that began after a dose change or a missed benzodiazepine dose needs a different review from longstanding worry.

A clinician may also consider a physical examination or targeted testing when the history suggests a medical contributor. NIMH describes a history and possible examination to evaluate physical explanations for anxiety; it doesn't prescribe the same lab panel for everyone. See NIMH's GAD overview.

I order testing to answer a clinical question. I don't diagnose anxiety from one ferritin, thyroid, vitamin or hormone result, set a universal "optimal" lab target, or postpone needed psychiatric care while waiting for every lab.

Bring existing results if you have them. New chest pain, fainting or severe shortness of breath requires urgent medical assessment, even if you've previously been told you have panic attacks.

What to bring to a medication review

Bring the actual medication pattern, not just the diagnosis label.

Names, formulations, doses and prescribing instructions for every medicine and supplement.
How often you actually take a benzodiazepine and how long you've used it.
Missed-dose symptoms, prior taper attempts, sedation, falls or memory problems.
Alcohol, cannabis, nicotine, caffeine, opioids and sleep medicines.
Previous treatment benefits and side effects, including sexual effects.
Your sleep pattern, panic or worry timeline, functioning and any relevant medical history.

Ask what each medicine is treating, how benefit will be assessed and what symptoms should trigger a call. If a change is proposed, ask who will coordinate it and what happens if withdrawal or worsening anxiety develops.

I want you to leave with an explanation you can use. No promise that one drug will solve every part of the picture.

Read how medication management works, or request a medication review.

When to get urgent help

Call 911 for a seizure, suspected overdose, slowed or difficult breathing, loss of consciousness, chest pain, severe shortness of breath or immediate danger of harming yourself or someone else. Severe confusion or hallucinations during withdrawal also needs emergency assessment.

If you have a seizure while taking Wellbutrin XL, the FDA label says to stop it and not restart it. Seek emergency care and contact the prescriber urgently.

For suicidal thoughts or a mental health crisis, call or text 988. New mania, psychosis, severe agitation or rapidly worsening depression needs urgent clinical assessment; call 911 if you cannot stay safe.

Medical Disclaimer: This article is education, not an individual treatment plan. Psychiatric medication, supplements and any medication taper require qualified medical supervision. Do not start, stop, taper, combine or change medicines on your own. The seizure-specific Wellbutrin XL instructions above are an urgent safety exception. Benzodiazepines must not be abruptly discontinued when physical dependence is possible. Pregnancy, breastfeeding, substance use, interactions and other medical conditions require a prescriber review.